Skip to main content
  • Book
  • Open Access
  • © 2020

Ethics and Drug Resistance: Collective Responsibility for Global Public Health

  • The first book to focus on ethical issues associated with antimicrobial resistance

  • Including theoretical/conceptual approaches, in-context analysis of specific topics, and interdisciplinary perspectives

  • Authors include world-leading figures in bioethics, public health ethics, law, epidemiology, and economics

  • Critically addresses trade-offs required in response to a growing problem predicted to kill more people than cancer by 2050

  • Essential reading for scholars in bioethics and public health ethics, physicians, public health practitioners, and policy makers

Part of the book series: Public Health Ethics Analysis (PHES, volume 5)

Buying options

Softcover Book USD 49.99
Price excludes VAT (USA)
Hardcover Book USD 59.99
Price excludes VAT (USA)

Table of contents (26 chapters)

  1. Front Matter

    Pages i-xvii
  2. Ethics and Drug Resistance in Context

    1. Front Matter

      Pages 1-1
    2. Drug-Resistant Infection: Causes, Consequences, and Responses

      • Euzebiusz Jamrozik, Michael J. Selgelid
      Pages 3-18Open Access
    3. Ethics and Antimalarial Drug Resistance

      • Phaik Yeong Cheah, Michael Parker, Nicholas P. J. Day
      Pages 55-73Open Access
    4. Antimicrobial Resistance and the Private Sector in Southeast Asia

      • Marco Liverani, Lauren Oliveira Hashiguchi, Mishal Khan, Richard Coker
      Pages 75-87Open Access
    5. Epidemiology and Ethics of Antimicrobial Resistance in Animals

      • Lisa Boden, Dominic Mellor
      Pages 109-121Open Access
  3. Theoretical Approaches to Ethics and Drug Resistance

    1. Front Matter

      Pages 123-123
    2. Access to Effective Diagnosis and Treatment for Drug-Resistant Tuberculosis: Deepening the Human Rights-Based Approach

      • Remmy Shawa, Fons Coomans, Helen Cox, Leslie London
      Pages 155-169Open Access
    3. The Right to Refuse Treatment for Infectious Disease

      • Carl H. Coleman
      Pages 171-182Open Access
    4. Surveillance and Control of Asymptomatic Carriers of Drug-Resistant Bacteria

      • Euzebiusz Jamrozik, Michael J. Selgelid
      Pages 183-201Open Access
    5. Conceptualizing the Impact of MDRO Control Measures Directed at Carriers: A Capability Approach

      • Morten Fibieger Byskov, Babette Olga Rump, Marcel Verweij
      Pages 203-224Open Access
    6. Fairness in the Use of Information About Carriers of Resistant Infections

      • John G. Francis, Leslie P. Francis
      Pages 243-256Open Access
    7. The Economics of Resistance Through an Ethical Lens

      • Richard D. Smith, Joanna Coast
      Pages 279-294Open Access

About this book

This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.


  • antimicrobial resistance
  • public health ethics
  • collective responsibility
  • infectious disease
  • global health
  • hospital acquired infection
  • animal ethics
  • animal epidemiology
  • TB resistance and human rights
  • TB resistance in developing countries
  • privacy and data collection
  • ethics and AMR regulation
  • ethics of drug development
  • antibacterial drug resistance
  • infectious diseases

Editors and Affiliations

  • Monash Bioethics Centre, Monash University, Melbourne, Australia

    Euzebiusz Jamrozik, Michael Selgelid

About the editors

Doctor Euzebiusz Jamrozik is a practising physician and bioethics PhD candidate in the Monash Bioethics Centre at Monash University, where he also completed an MA in Bioethics after prior studies in medicine and philosophy at University of Western Australia. His multidisciplinary interests include infectious disease, public health ethics, and epidemiology. Among other topics, his recent publications focus on ethical implications of vaccination, vector-borne disease, human challenge studies, and climate change impact on infectious disease. He is a Fellow of the Royal Australasian College of Physicians (FRACP) and Member of the World Health Organization (WHO) Collaborating Centre for Bioethics at Monash University.

Professor Michael Selgelid is Director of the Monash Bioethics Centre and the World Health Organization (WHO) Collaborating Centre for Bioethics at Monash University in Melbourne, Australia.  His research primarily focuses on public health ethics, infectious disease ethics, research ethics, and ethical issues associated with biotechnology and other emerging technologies.  He edits a book series in Public Health Ethics Analysis for Springer and is Co-Editor of Monash Bioethics Review.  Michael earned a BS in Biomedical Engineering from Duke University and a PhD in Philosophy from the University of California, San Diego.

Bibliographic Information

  • Book Title: Ethics and Drug Resistance: Collective Responsibility for Global Public Health

  • Editors: Euzebiusz Jamrozik, Michael Selgelid

  • Series Title: Public Health Ethics Analysis

  • DOI:

  • Publisher: Springer Cham

  • eBook Packages: Religion and Philosophy, Philosophy and Religion (R0)

  • Copyright Information: The Editor(s) (if applicable) and The Author(s) 2020

  • License: CC BY

  • Hardcover ISBN: 978-3-030-27873-1

  • Softcover ISBN: 978-3-030-27876-2

  • eBook ISBN: 978-3-030-27874-8

  • Series ISSN: 2211-6680

  • Series E-ISSN: 2211-6699

  • Edition Number: 1

  • Number of Pages: XVII, 448

  • Number of Illustrations: 1 b/w illustrations

  • Topics: Bioethics, Medical Microbiology, Diseases

Buying options

Softcover Book USD 49.99
Price excludes VAT (USA)
Hardcover Book USD 59.99
Price excludes VAT (USA)